About
Alvaro Guillem is the Board Observer of Renibus Therapeutics. He co-founded ZS Pharma in 2008. He is a veteran of the pharmaceutical industry with over 30 years of leadership experience in bringing new therapies to market at both well-established and start-up companies. Prior to ZS Pharma, he held senior positions at Genzyme/Bone Care, Wyeth and Boeringher Ingelheim, as well as at start-up companies such as Medeva Americas and Adams Respiratory Therapeutics. Most recently, Al held the role of Vice President of Quality and Scientific Affairs at Ash Access Technology, which developed a catheter lock for patients with ESRD on dialysis. Al holds a B.S. in chemistry from Mary Washington University and a Ph.D. in chemistry from Virginia Commonwealth University.
Investment Focus
- Location
- Dallas, US
Contact Information
Find more investors like Alvaro
Search Investors